-
-
-
A196969-1000UNThe content of this cell is too long for an XLSX file (more than 32767 characters). Please use the CSV format for this export.
-
A196969-250UNThe content of this cell is too long for an XLSX file (more than 32767 characters). Please use the CSV format for this export.
-
Ab089824-100μlRabbit anti Human ASK1 Antibody, Polyclonal antibody, could be used for WB, IHC and so on.Application:WB: 1/500-1/2000IHC: 1/50-1/100Protein Function:Component of a protein kinase signal transduction cascade. Phosphorylates and activates MAP2K4 and
-
Ab089824-10μlRabbit anti Human ASK1 Antibody, Polyclonal antibody, could be used for WB, IHC and so on.Application:WB: 1/500-1/2000IHC: 1/50-1/100Protein Function:Component of a protein kinase signal transduction cascade. Phosphorylates and activates MAP2K4 and
-
Ab089824-1mlRabbit anti Human ASK1 Antibody, Polyclonal antibody, could be used for WB, IHC and so on.Application:WB: 1/500-1/2000IHC: 1/50-1/100Protein Function:Component of a protein kinase signal transduction cascade. Phosphorylates and activates MAP2K4 and
-
Ab089824-50μlRabbit anti Human ASK1 Antibody, Polyclonal antibody, could be used for WB, IHC and so on.Application:WB: 1/500-1/2000IHC: 1/50-1/100Protein Function:Component of a protein kinase signal transduction cascade. Phosphorylates and activates MAP2K4 and
-
Ab177886-100μgAstegolimab (anti-IL-1RL1) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab (anti-IL-1RL1) has the potential for chronic obstructive pulmonary disease (COPD) research.
-
Ab177886-10mgAstegolimab (anti-IL-1RL1) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab (anti-IL-1RL1) has the potential for chronic obstructive pulmonary disease (COPD) research.
-
Ab177886-1mgAstegolimab (anti-IL-1RL1) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab (anti-IL-1RL1) has the potential for chronic obstructive pulmonary disease (COPD) research.
-
Ab177886-5mgAstegolimab (anti-IL-1RL1) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. Astegolimab (anti-IL-1RL1) has the potential for chronic obstructive pulmonary disease (COPD) research.